Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02879812 · ClinicalTrials.gov registry record · NA
Disparities in National Kidney Allocation Policy
A NA study of Kidney Disorders, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 56,332
- Enrollment target
- 3
- Study locations
NCT02879812 is a NA study of Kidney Disorders that has completed, run by Emory University. The registered enrollment target is 56,332 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT02879812, a NA study of Kidney Disorders, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 56,332 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of the current study is to test a systems-level approach to disseminate a multicomponent, multilevel intervention consisting of educational materials about transplantation and the new kidney allocation system targeting dialysis facility medical directors, staff, and patients. Roughly 750 dialysis facilities in up to 18 End Stage Renal Disease Network regions across the United States will be randomized to receive intervention materials. The overall goal of the study is to extend the influence of the national allocation policy in reducing disparities in early steps in kidney transplant access.
Conditions Studied
Interventions
- OTHER Standard Care
- OTHER Performance Feedback Reports
- OTHER Educational Video for Staff
- OTHER Educational Video for Patients
- OTHER Educational Webinar
Study Locations (3)
Georgia
- Emory Clinic - Atlanta
- Emory University Hospital - Atlanta
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56,332 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02879812
The ClinicalTrials.gov registry entry for NCT02879812 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56,332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Disorders appearing as the primary indexed condition, and to 5 interventions - of which Standard Care is the first listed.
NCT02879812 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02879812 about?
NCT02879812 is a clinical study titled "Disparities in National Kidney Allocation Policy". The purpose of the current study is to test a systems-level approach to disseminate a multicomponent, multilevel intervention consisting of educational materials about transplantation and the new kidney allocation system targeting dialysis facility medical directors, staff, and patients. Roughly 750...
What is the current status of trial NCT02879812?
This trial is currently completed. It is a NA study. The enrollment target is 56,332 participants. The study started on 2016-09. Estimated completion is 2019-08-02.
What conditions does trial NCT02879812 study?
This clinical trial studies the following conditions: Kidney Disorders.
What interventions are being tested in trial NCT02879812?
The interventions under investigation include: Standard Care (OTHER), Performance Feedback Reports (OTHER), Educational Video for Staff (OTHER), Educational Video for Patients (OTHER), Educational Webinar (OTHER).
Who is sponsoring clinical trial NCT02879812?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02879812 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.